Author Login

Correspondence to Author: Kulshrestha Ritu¹, Meenu Rani². 

1. Director Professor & Head, Department of Pathology, V.P.Chest Institute, University of Delhi.
2. PhD Scholar, Department of Pathology, V.P.Chest Institute, University of Delhi.

DOI: 10.52338/tejoc.2025.4798

Abstract:

Lung cancer has a high prevalence and low survival rate in India due to patients presenting at late-stage. The National Cancer Control programs and Tobacco cessation programs are working to improve their diagnosis and management. However, there are no public health programs for Lung Cancer Screening in India.
The early detection/Screening for Lung Cancer in India is vital for improving patient outcomes and is the emergent need of this decade. The unique risk factors predisposing to lung cancer, epidemiological variations across various geographical regions of India, multistep carcinogenesis, proteogenomics associated with lung cancer are focus areas of developing screening parameters specific to our country. In this review, we collate the available data of Lung Cancer from India. We explore the potential applicability of the National Digital health Mission started in India in 2020, for initiating the lung cancer screening programme. Further we assess the applicability of upcoming newer technologies using Artificial intelligence in creating a Lung cancer screening module in association with Digital healthcare programme in India to benefit the 1.5 billion population of India.

Keywords:Lung Cancer Screening, India, Artificial Intelligence, LDCT.

Citation:

Kulshrestha Ritu, Lung Cancer Screening in India: Role of Digital healthcare and Artificial Intelligence: Where do we stand and future perspectives. The European Journal of Cancer 2025.